Showing results (421-430 of 429) with videos related to
Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 429 results.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.Oncotarget|August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerMeng-Lay Lin, Hetal Patel, Judit Remenyi, et al.Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trialsDonald A Berry, Naoto T Ueno, Marcella M Johnson, et al.JCO Precision Oncology|May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast CancerJacqueline A Shaw, Karen Page, Evie Wren, et al.BMJ Open|August 30, 2023
Longitudinal cohort study investigating neurodevelopmental and socioemotional outcomes in school-entry aged children after open heart surgery in Australia and New Zealand: the NITRIC follow-up study protocolDebbie Long, Vicki A Anderson, Louise Crossley, et al.Journal of Neurointerventional Surgery|January 30, 2026
Post-approval study 3-year outcomes of the Neuroform Atlas stent for the treatment of wide-necked intracranial aneurysmsBrian Jankowitz, Ashutosh P Jadhav, Bradley Gross, et al.Journal of Neurointerventional Surgery|March 16, 2021
Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomesBrian T Jankowitz, Ashutosh P Jadhav, Bradley Gross, et al.Human Molecular Genetics|May 23, 2003
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiencyN A Alam, A J Rowan, N C Wortham, et al.Pageof 43